Physician

Thomas A Barnard, MD

According to 2025 Medicare claims, Thomas Barnard, MD (NPI: 1487654117) practices ophthalmology in the Deltona-Daytona Beach-Ormond Beach, FL market, with the plurality of this provider's patient population coming from Volusia, FL. This provider's primary affiliated billing organization is RETINA VITREOUS CONSULTANTS (NPI: 1699773796; TIN: 592086792) and primary practice location at 32746-2175.

Barnard's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,613 traditional Medicare patients, billed 33,729 HCPCS/CPT codes, and received $4,686,979 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,590 prescription claims across 452 beneficiaries totaling $509,700 in drug costs, led by Eylea (Aflibercept). Open Payments data shows 45 records totaling $959. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,729,036 to $4,686,979. Similarly, Part D prescription costs have risen steadily, from $178,151 to $509,700. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.3M$4.7M2015 Medicare payment: $2,729,036 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,590,115 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,423,846 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,830,084 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,593,628 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,757,429 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,628,152 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,121,904 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,514,604 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,686,979 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152,28626,512$2,729,036
20161,92224,697$2,590,115
20171,85721,344$2,423,846
20181,93021,708$2,830,084
20191,81722,577$3,593,628
20201,74220,182$3,757,429
20211,66019,725$3,628,152
20221,81423,317$4,121,904
20231,66834,180$4,514,604
20241,61333,729$4,686,979

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$399K$799K2015 Drug cost: $178,151 (USD; Tot_Drug_Cst)2016 Drug cost: $193,569 (USD; Tot_Drug_Cst)2017 Drug cost: $251,890 (USD; Tot_Drug_Cst)2018 Drug cost: $160,100 (USD; Tot_Drug_Cst)2019 Drug cost: $224,780 (USD; Tot_Drug_Cst)2020 Drug cost: $271,942 (USD; Tot_Drug_Cst)2021 Drug cost: $206,977 (USD; Tot_Drug_Cst)2022 Drug cost: $506,946 (USD; Tot_Drug_Cst)2023 Drug cost: $798,980 (USD; Tot_Drug_Cst)2024 Drug cost: $509,700 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015300931$178,151
20163091,048$193,569
2017284914$251,890
20183191,032$160,100
20192931,012$224,780
2020280978$271,942
20213621,163$206,977
20224251,369$506,946
20234261,520$798,980
20244521,590$509,700

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye5752,461$96
92014Established patient complete exam of visual system8981,052$84
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more565782$66
92134Imaging of retina9082,387$29
92250Photography of the retina1,1431,312$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EyleaAflibercept1093,294$271,584
VabysmoFaricimab-Svoa29812$83,877
SyfovrePegcetacoplan/Pf18485$65,700
RestasisCyclosporine15630$13,391
Prednisolone AcetatePrednisolone Acetate33912,160$12,163

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.45$959Alimera Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Thomas A. Barnard, MD?

Tedicare shows public-source Medicare data for Thomas A. Barnard, MD (NPI 1487654117), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas A. Barnard, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Thomas A. Barnard, MD?

Thomas A. Barnard, MD is linked to RETINA VITREOUS CONSULTANTS (billing NPI 1699773796) in the available physician profile data.

Does Thomas A. Barnard, MD have Open Payments data?

Thomas A. Barnard, MD has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.